Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

remogliflozin etabonate MeSH Supplementary Concept Data 2025


MeSH Supplementary
remogliflozin etabonate
Unique ID
C532127
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C532127
Entry Term(s)
4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-beta-D-glucopyranoside
Pharm Action
Sodium-Glucose Transporter 2 Inhibitors
Registry Numbers
TR0QT6QSUL
Heading Mapped to
*Glucosides
*Pyrazoles
Frequency
24
Note
orally administered hypoglycemic agent; structure in first source
Source
J Pharmacol Exp Ther 2008 Oct;327(1):268-76
Date of Entry
2008/10/07
Revision Date
2018/09/24
remogliflozin etabonate Preferred
page delivered in 0.004s